Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filters

PublicationDisease areaApplication areaSample typeProducts

Frontiers in Cardiovascular Medicine, 2024
Plasma proteomics and carotid intima-media thickness in the UK biobank cohort

Chen M., Kho P., Guarischi-Sousa R. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Frontiers in Endocrinology, 2024
Differential expression of cardiometabolic and inflammation markers and signaling pathways between overweight/obese Qatari adults with high and low plasma salivary α-amylase activity

Khalifa O., Al-Akl N., Arredouani A.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPatient StratificationPlasma

Nature Medicine, 2024
Cytokine-mediated CAR T therapy resistance in AML

Bhagwat A., Torres L., Shestova O. et al.

Olink Explore HTOncologyPathophysiologyPlasma

Nature Medicine, 2024
Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesity

Huang Y., Sulek K., Stinson S. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Atherosclerosis, 2024
Relationship of proteins and subclinical cardiovascular traits in the population-based LIFE-Adult study

Garcia T., Petrera A., Hauck S. et al.

Olink Target 96CVDPathophysiologyPatient StratificationSerum

Clinical Immunology, 2024
Insights into the multifaceted role of interleukin-37 on human immune cell regulation

Teufel L., Matzaraki V., Folkman L. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

mBio, 2024
SARS-CoV-2 infection induces hyaluronan production in vitro and hyaluronan levels in COVID-19 patients relate to morbidity and long-term lung impairment: a prospective cohort study

Hellman U., Rosendal E., Lehrstrand J. et al.

Olink Target 48Infectious DiseasesPathophysiologyCell Culture Supernatant

Healthcare, 2024
The Mediating Roles of Lung Function Traits and Inflammatory Factors on the Associations between Measures of Obesity and Risk of Lower Respiratory Tract Infections: A Mendelian Randomization Study

Ma X., Zhu P., Yang Q. et al.

Olink Target 96Metabolic DiseasesRespiratory DiseasesPathophysiologyPlasma

Scientific Reports, 2024
Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes

Rabin A., Bello E., Kumar S. et al.

Olink Target 96NeurologyPatient StratificationCSF

International Journal of Molecular Sciences, 2024
Regenerating Family Member 3 Alpha Is Predictive of Mortality Following Emergent Large Vessel Occlusion

Sands M., McLouth C., Frank J. et al.

Olink Target 96CVDNeurologyPatient StratificationPlasma

Biomolecules, 2024
Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 Patients

McLarnon T., McDaid D., Lynch S. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

Environmental Advances, 2024
Per-and polyfluoroalkyl substances and disrupted sleep: mediating roles of proteins

Li S., Goodrich J., Chen J. et al.

Olink Explore 3072/384Environmental Health & ToxicologyPathophysiologyPlasma

Cardiovascular Research, 2024
Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF

Tubben A., Markousis-Mavrogenis G., Meems L. et al.

Olink Target 96CVDPatient StratificationSerum

Scientific Reports, 2024
Proteomic Mendelian randomization to identify protein biomarkers of telomere length

Zhao J., Yang K., Lu Y. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Alzheimer's & Dementia, 2024
Inflammatory protein associations with brain MRI measures: Framingham Offspring Cohort

Chen J., Ragab A., Doyle M. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Dermatology and Therapy, 2024
Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial

Catlett I., Gao L., Hu Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum

Scientific Reports, 2024
Genomic study of taste perception genes in African Americans reveals SNPs linked to Alzheimer’s disease

Joseph P., Abbas M., Goodney G. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Nature Communications, 2024
Genome-wide discovery and integrative genomic characterization of insulin resistance loci using serum triglycerides to HDL-cholesterol ratio as a proxy

DeForest N., Wang Y., Zhu Z. et al.

Olink Explore 3072/384Metabolic DiseasesCross-platform ValidationPlasma

eBioMedicine, 2024
Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses

Wang S., Viallon V., Lee M. et al.

Olink Target 96Olink Explore 3072/384OncologyPathophysiologyPlasma

Cell Reports, 2024
Multi-trait analysis reveals risk loci for heart failure and the shared genetic etiology with blood lipids, blood pressure, and blood glucose

Zhu Y., Wang Y., Cui Z. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

2124 publications